Merck & Co Inc said on Thursday it would buy drug developer Immune Design Corp for nearly $300 million, to gain access to its immunotherapy programs.

https://ift.tt/2GH3MML support@endlesssupplies.biz (Endless Supplies .Biz) February 21, 2019 at 07:02AM
No comments:
Post a Comment